Our Research.

Advancing the science of continuous neurological monitoring. Our peer-reviewed research and clinical studies validate ActualSignal's approach to objective, real-world Parkinson's disease assessment.

90,000+

Video assessments

10,000+

Days of days
with activity data

30,000+

Patient reported
data points

500+

Monitored patients

Journal Article · 2026 · Featured

Validation of smartphone-based finger-tapping assessment for remote bradykinesia monitoring in Parkinson's disease

Iserovich H, Cohen R, Martinez L, et al.

Movement Disorders Clinical Practice — In collaboration with Kansas University Medical Center

This IRB-approved clinical investigation evaluates the accuracy of ActualSignal's computer vision pipeline for scoring bradykinesia via smartphone-recorded finger-tapping tests against gold-standard MDS-UPDRS Part III examinations.

Conference Poster · March 2026

Real-world remote therapeutic monitoring in Parkinson's disease: engagement and clinical utility across four Florida neurology clinics

Iserovich H, Cohen R, et al.

Presented at 24th Annual Parkinson Educational Symposium, Norman Fixel Institute

Engagement metrics and clinical intervention outcomes from commercial RTM deployments across four neurology clinics, demonstrating 90% monthly eligibility rates and 15 successful care management interventions.

White Paper · 2025

From monitoring to care delivery: a Services-as-Software framework for value-based neurological care

Iserovich H, ActualSignal Research Team

ActualSignal Technical Reports

This white paper outlines ActualSignal's three-tier platform strategy — Monitor, Detect, Deliver — and its alignment with ACO shared-risk models and Medicare Advantage economics for scalable neurological care.